The trials have not begun. The signing of MOU is an indication that those clinics are interested in the product. Most areas will require FDA approval before they can actually begin trialing. Read the previous announcements. The earliest trial will begin around end of March, from memory, in the Australian Monash clinic.
This stock is def going up, imho. The amount of profit they can generate will rocket soon as they are able to receive orders.
Ann: TWO MORE KEY OPINION LEADERS APPOINTED, page-8
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
